TRAD CHI MED (00570) Company Profile - Company Info, Industry & Management

返回 Overview News Financials Shareholders Valuation Profile

Industry

Innovative Drugs & Biologics 0.02%

124 stocks in this industry

3 >7%

3 5~7%

10 3~5%

36 0~3%

15 0%

38 0~3%

13 3~5%

1 5~7%

5 >7%

Down 52 Up 57

Industry RankingsValue (HKD)Rank

Revenue (Last FY)17.29B13/112

Net Profit (Last FY)-401.13M103/125

ROE (Last FY)-1.67%56/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition

GUO Jinhong Executive Director

LI Hongjian Executive Director

PENG Li Executive Director

LI Xiangrong Non-Executive Director

ZU Jing Non-Executive Director

XU Jinghui Non-Executive Director

CHEN Kun Non-Executive Director

HUANG Hao Non-Executive Director

XIE Rong Independent Non-Executive Director

YU Tze Shan Hailson Independent Non-Executive Director

QIN Ling Independent Non-Executive Director

LI Weidong Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-07-17.

About this page

This page shows TRAD CHI MED (00570) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

TRAD CHI MED 00570

Company Information

Industry

Management

TRAD CHI MED 00570·

Company Information

Industry

Management

TRAD CHI MED 00570